Title |
Efficient gene targeting by TAL effector nucleases coinjected with exonucleases in zygotes
|
---|---|
Published in |
Scientific Reports, February 2013
|
DOI | 10.1038/srep01253 |
Pubmed ID | |
Authors |
Tomoji Mashimo, Takehito Kaneko, Tetsushi Sakuma, Junya Kobayashi, Yayoi Kunihiro, Birger Voigt, Takashi Yamamoto, Tadao Serikawa |
Abstract |
TAL Effector Nucleases (TALENs) are versatile tools for targeted gene editing in various species. However, their efficiency is still insufficient, especially in mammalian embryos. Here, we showed that combined expression of Exonuclease 1 (Exo1) with engineered site-specific TALENs provided highly efficient disruption of the endogenous gene in rat fibroblast cells. A similar increased efficiency of up to ~30% with Exo1 was also observed in fertilized rat eggs, and in the production of knockout rats for the albino (Tyr) gene. These findings demonstrate TALENs with Exo1 is an easy and efficient method of generating gene knockouts using zygotes, which increases the range of gene targeting technologies available to various species. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 3 | 75% |
United States | 1 | 25% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 75% |
Scientists | 1 | 25% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 1% |
Japan | 2 | 1% |
Italy | 1 | <1% |
Turkey | 1 | <1% |
Bulgaria | 1 | <1% |
Slovenia | 1 | <1% |
Unknown | 144 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 41 | 27% |
Student > Ph. D. Student | 32 | 21% |
Student > Master | 20 | 13% |
Student > Bachelor | 17 | 11% |
Professor > Associate Professor | 9 | 6% |
Other | 23 | 15% |
Unknown | 10 | 7% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 88 | 58% |
Biochemistry, Genetics and Molecular Biology | 32 | 21% |
Medicine and Dentistry | 6 | 4% |
Neuroscience | 4 | 3% |
Engineering | 3 | 2% |
Other | 8 | 5% |
Unknown | 11 | 7% |